Searchable abstracts of presentations at key conferences in endocrinology

ea0094op8.2 | Late Breaking Abstracts Respectively | SFEBES2023

Subcutaneous Levothyroxine as an alternative long-term treatment for refractory hypothyroidism: A case report

Chaudhury Nadia , Crasto Winston , Patel Vinod

Background: Refractory hypothyroidism poses a clinical dilemma, with great difficulty to treat. Novel cases have targeted intramuscular (IM) levothyroxine (LT4) as a potential treatment for cases resistant to oral LT4. We discuss a patient who became intolerant of IM LT4 after 18 years of treatment, thus SC LT4 was initiated as alternative management.Case Presentation: 35-year-old female with diagnosed Schmidt’s Syn...

ea0037ep762 | Pituitary: clinical | ECE2015

Adult inpatients on desmopressin: a patient safety initiative using e-prescribing

Bonfield Adam , Crasto Winston , Hackett Elizabeth , Gleeson Helena

Background: Errors made with critical medicines such as desmopressin and hydrocortisone used in the treatment of endocrine conditions in hospitalised patients can undermine patient safety but are largely preventable.Methods: Retrospective audit of adult patients admitted at the University Hospitals of Leicester NHS Trust between January 2013 and June 2014, prescribed desmopressin for cranial diabetes insipidus (CDI) or other medical conditions using elec...

ea0015p392 | Thyroid | SFEBES2008

Audit of outcomes of radioiodine treatment for benign thyroid disease

Bejinariu Emanuela , Crasto Winston , Elrishi Mohamed A , Levy Miles J , Peat I , Howlett Trevor A

Objective: To assess the effect of antithyroid drug pretreatment on radioiodine (I-131) treatment outcomes for benign thyroid disease.Method: Retrospective analysis of all patient records on the clinical database that underwent I-131 treatment for benign thyroid disease between 1989 and 2007.Results: About 544 patients were identified, 98 males (18%) and 446 females (82%). The mean age was 54 years (11-88). 464 patients (85.3%) we...